Wadzanai Samaneka

机构：University of Zimbabwe · ORCID：0000-0003-0215-9309

发表论文 56 篇 · 总被引 1414 次 · h-index 18

代表论文

• Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings (2023 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 15)
• Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349) (2022 · Clinical Infectious Diseases · 被引 14)
• Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial (2025 · Clinical Infectious Diseases · 被引 8)
• Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials (2026 · The Lancet HIV · 被引 7)
• Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention (2024 · Clinical Infectious Diseases · 被引 6)
• Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group (2023 · PLoS ONE · 被引 6)